NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older leukemia patients: trial tests stronger drug combos
Disease control Recruiting nowThis study is testing whether adding one of two extra drugs to a standard leukemia treatment works better for older adults or those who cannot tolerate intensive chemotherapy. Researchers want to see if these new combinations can kill leukemia cells more effectively, prevent drug…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for frail leukemia patients: 3-Drug combo targets Treatment-Resistant cancer
Disease control Recruiting nowThis study is testing whether adding a drug called chidamide to an existing two-drug combination (venetoclax and azacytidine) works better for newly diagnosed acute monocytic leukemia patients who are too old or frail for intensive chemotherapy. The trial aims to see if this thre…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Experimental drug targets tough blood cancers in first human trial
Disease control Recruiting nowThis study is testing a new drug called MP0533 for the first time in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Researchers want to find the safest dose and see if it helps control these blood cancers. The trial will include up to 249 adults whose…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Researchers probe why Life-Saving transplants are missed
Knowledge-focused Recruiting nowThis study aims to understand the barriers that prevent eligible blood cancer patients from receiving a potentially curative stem cell transplant. Researchers will observe over 1,300 adults with acute leukemia, myelodysplastic syndrome, or myeloproliferative neoplasms to track wh…
Matched conditions: NEWLY DIAGNOSED
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC